This systematic review and meta-analysis assessed the use of methylene blue (MB) for managing septic shock in critically ill adults. The findings suggest that MB may reduce short-term mortality, the need for vasopressors, and hospital stay duration, with no significant increase in adverse events. However, the evidence is of low
